Daily Archives: October 24, 2018
Epidemiology and Management of Hepatocellular Carcinoma
The major risk factors for hepatocellular carcinoma (HCC) in a contemporary clinical practice is becoming increasingly related to post sustained virological response hepatitis C, suppressed hepatitis B virus on treatment, alcoholic and non-alcoholic fa… Continue reading
What are the Benefits of a Sustained Virologic Response to Direct-acting Antiviral Therapy for HCV Infection?
Direct-acting antiviral (DAA) regimens are safe and effective at eradicating hepatitis C virus (HCV) infection. Unfortunately, DAAs remain expensive, so treatment of all HCV-infected patients would substantially affect healthcare costs. It is therefore… Continue reading
Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection
Fewer than 1% of chronic hepatitis B virus (HBV) infections per year are cured with antiviral treatment. This creates a need for long-term treatment, which poses challenges for patients and health systems. Since cure is accompanied by recovery of antiv… Continue reading
Chef from Vienna to be at VUMC Oct. 29 and 30
New credentialing software to launch Nov. 5
To make the credentialing and privileging process more intuitive and streamlined for clinicians, Vanderbilt University Medical Center is implementing a new credentialing software suite known as “Cactus.” Continue reading
Antipsychotics ineffective for treating ICU delirium: study
Critically ill patients are not benefiting from antipsychotic medications that have been used to treat delirium in intensive care units (ICUs) for more than four decades, according to a study released today in the New England Journal of Medicine. Continue reading
“VUMC Voice” 8-to-12 year old Halloween art contest winners announced
Zombies! The Grim Reaper! Ghosts! A pineapple jack-o-lantern! Continue reading